NCT06113185

Brief Summary

The aim of this study was to examine the Turkish validity of the Pain Behavior Scale in a population with chronic non-specific low back pain and to examine both intra-rater and inter-rater reliability. In addition, since this test package includes a series of functional activities, it is aimed to assess pain behaviors during functional movement in this population and to verify the test-retest reliability of physical performance tests.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

February 21, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

8 months

First QC Date

October 24, 2023

Last Update Submit

August 13, 2024

Conditions

Keywords

Psychometric PropertiesPain Behavior Scale

Outcome Measures

Primary Outcomes (3)

  • Pain Behavior Scale

    The Pain Behavior Scale was developed to record the presence and severity of pain behaviors exhibited during physical performance tests. Specific pain behaviors assessed are sighing, breath holding, grimacing, guarding, rubbing and antalgic gait. The Pain Behavior Scale consists of a 4-point scale ranging from "None" (no observed behavior) to "Severe" (marked pain behavior). Two measures are obtained from the scale 1. The presence or absence of each behavior 2. Total score for the severity of general pain behaviors. The scale will be used during the implementation of physical performance tests lasting 10-15 minutes.

    At the beginning of the study and up to 1 weeks

  • Visual Analog Scale

    The Visual Analog Scale, which is used to record the intensity of pain, consists of a single 10 cm line; the left end is described as "No pain" and the right end is described as "The most severe pain experienced in life". Patients will be asked to mark the severity of their current pain on the 10 cm line. During the calculation, the marked point will be measured in cm. The higher the score, the more severe the pain.

    At the beginning of the study

  • McGill Pain Questionnaire-Short Form

    The McGill Pain Questionnaire Short Form consists of three parts. In the first part, patients are asked to describe their pain with 15 descriptive words (11 sensory and 4 affective). In the second part, the severity of the patient's pain is evaluated. In the third part, patients are asked to mark their current pain intensity on a visual comparison scale.

    At the beginning of the study

Secondary Outcomes (2)

  • Oswestry Disability Index

    At the beginning of the study

  • Fear-Avoidance Beliefs Questionnaire

    At the beginning of the study

Interventions

surveyOTHER

Demographic and clinical information of the participants will be recorded using a standardized form. The cognitive status of the patient will be evaluated according to the answers to the questions asked to the patient during the questioning of demographic data and reading and signing the consent form. The participants will be asked to complete a series of questionnaires to assess pain intensity and characteristics, pain-related functional disability, and pain-related fear-avoidance behavior. To record the presence and severity of pain behaviors exhibited during physical performance tests, patients will be asked to complete 5 functional tests (repetitive trunk flexion, repetitive sit-to-stand, timed get-up-and-go test, reach with load, 50-step walk test) and observers will simultaneously complete the Pain Behavior Scale. Each participant will be asked to attend two testing sessions separated by one week and occurring before the start of treatment.

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients on the waiting list with a diagnosis of chronic nonspecific low back pain who applied to the Physical Therapy and Rehabilitation Outpatient Clinic of Acıbadem Health Group hospitals with complaints of low back pain will participate in the study.

You may qualify if:

  • Non-specific low back pain for more than three months
  • Being between the ages of 18-55
  • Adequate cognitive functions (reading, writing, recall, orientation, language)

You may not qualify if:

  • Presence of a serious underlying pathology (e.g. cancer, infection or cauda equina syndrome)
  • Presence of spinal stenosis
  • Presence of signs of radiculopathy (presence of neural symptoms such as pain radiating to the lower extremities, weakness, numbness and tingling sensation)
  • Presence of fracture or surgical history in the relevant area
  • Presence of rheumatic disease history
  • Presence of pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acıbadem Health Group

Istanbul, None Selected, 34752, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Elif E Safran, asst. prof.

    Acibadem Healthcare Group

    PRINCIPAL INVESTIGATOR
  • Irmak Çavuşoğlu, asst. prof.

    Acibadem Healthcare Group

    STUDY CHAIR
  • Nuray Alaca, assoc. prof.

    Acibadem Healthcare Group

    STUDY DIRECTOR

Central Study Contacts

Elif E Safran, asst. prof.

CONTACT

Nuray Alaca, assoc. prof.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2023

First Posted

November 2, 2023

Study Start

February 21, 2024

Primary Completion

November 1, 2024

Study Completion

January 1, 2025

Last Updated

August 15, 2024

Record last verified: 2024-08

Locations